Home Department: Biology
Mentor: Irving Weissman, Pathology and Developmental Biology

CD47 is a surface protein expressed on every cancer cell which functions as a “don’t eat me” signal and allows tumor cells to flourish.  Currently, there are clinical trials with antibodies that target and bind to CD47 to remove the “don’t eat me” signal and allow immune cells to kill the cancer cells. Kevin’s Stanford Bio-X project will aim to discover how different genetic variants of CD47 change the efficacy of these treatments in hopes of developing better treatments for future cancer patients.